Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Ultragenyx Pharmaceutical Inc.

Burst CME™ – Understanding Fatty Acid Oxidation Disorders (FAODs) PART II: Hope on the Horizon

Release Date: March 10, 2020
Expiration Date: March 10, 2021
Media: Internet - based

Activity Overview

Burst CME™: Understanding Fatty Acid Oxidation Disorders (FAODs) is a brief online activity featuring written text and expert audio commentary regarding the current standard of care and emerging options for the treatment and prevention of long-chain fatty acid oxidation disorders (LC-FAODs). Nicola Longo, MD, is a professor and chief of the Division of Pediatric Genetics at the University of Utah in Salt Lake City, Utah. During this online program, he answers important questions and offers his perspectives on the management of LC-FAODs.

This activity is part two of a two-part Burst CME series. Click here to visit the companion Burst CME activity.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Ultragenyx Pharmaceutical Inc.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio content until you finish the presentation.
  • At the end of the activity, “Educational Content/Audio” will be available for your reference.
  • In order to receive a CME/CE Certificate, you must complete the activity.
  • Complete the Posttest and Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE Certificate upon completion of these steps.

Target Audience

This educational activity is directed toward pediatricians, PCPs, endocrinologists, NPs, PAs, and additional health care professionals involved in the care of patients with metabolic disorders.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Review nonpharmacologic and pharmacologic approaches to acute and long-term management of patients with long-chain fatty acid oxidation disorders (LC-FAODs).
  • Evaluate clinical efficacy and safety data for novel therapeutic agents.

Faculty, Staff, and Planners’ Disclosures


Nicola Longo
Nicola Longo, MD, PhD
Professor and Chief
Division of Pediatric Genetics
University of Utah
Salt Lake City, UT

Disclosures: Grant/Research Support: Aeglea, Amicus, BioMarin, Censa, Genzyme, Horizon, Moderna, Pfizer, Protalix, Retrophin, Takeda, Ultragenyx; Consultant: Aeglea, Amicus, BioMarin, Censa, Chiesi, Genzyme, Hemoshear, Horizon, Moderna, Takeda, Synlogic.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician and nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or the company that provided commercial support.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By